Molecular classification in fertility-sparing treatment of endometrial carcinoma and atypical endometrial hyperplasia

被引：0
|
作者：
Martin, Tiermes Marina [1 ,2 ]
Matas, Isabel [1 ]
Munmany, Meritxell [1 ]
Celada, Cristina [1 ]
Diaz-Feijoo, Berta [1 ,2 ]
Glickman, Ariel [1 ]
Carreras, Nuria [1 ]
Fuste, Pere [1 ]
Torne, Aureli [1 ,2 ]
机构：
[1] Hosp Clin Barcelona, Clin Inst Gynecol Obstet & Neonatol ICGON, Barcelona, Spain
[2] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2024年 / 34卷 / SUPPL_1期
关键词：
D O I：
10.1136/ijgc-2024-ESGO.478
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1154
引用
收藏
页码：A245 / A246
页数：2
相关论文
共 50 条
  • [1] A practical guideline on the fertility-sparing treatment of patients with endometrial carcinoma and atypical endometrial hyperplasia
    Catena, Ursula
    Macklon, Kirsten Louise Tryde
    Rodolakis, Alexandros
    Scambia, Giovanni
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025,
  • [2] Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
    Chen, Junyu
    Cao, Dongyan
    Yang, Jiaxin
    Yu, Mei
    Zhou, Huimei
    Cheng, Ninghai
    Wang, Jinhui
    Zhang, Ying
    Peng, Peng
    Shen, Keng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Fertility-sparing management of endometrial cancer and atypical hyperplasia
    Gonthier, C.
    Trefoux-Bourdet, A.
    Luton, D.
    Koskas, M.
    GYNECOLOGIE OBSTETRIQUE FERTILITE & SENOLOGIE, 2017, 45 (02): : 112 - 118
  • [4] Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol
    Maria-Eulalia Fernandez-Montoli
    Jordi Sabadell
    Nayanar-Adela Contreras-Perez
    Advances in Therapy, 2021, 38 : 2717 - 2731
  • [5] Fertility-Sparing Treatment for Atypical Endometrial Hyperplasia and Endometrial Cancer: A Cochrane Systematic Review Protocol
    Fernandez-Montoli, Maria-Eulalia
    Sabadell, Jordi
    Contreras-Perez, Nayanar-Adela
    ADVANCES IN THERAPY, 2021, 38 (05) : 2717 - 2731
  • [6] The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: A debated therapeutic option
    Gadducci, Angiolo
    Spirito, Nicoletta
    Baroni, Elena
    Tana, Roberta
    Genazzani, Andrea Riccardo
    GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (10) : 683 - 691
  • [7] Fertility-sparing treatment for patients with endometrial carcinoma
    Ind, T.
    FACTS VIEWS AND VISION IN OBGYN, 2023, 15 (01): : 1 - 2
  • [8] Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasia
    Zhang, Xiaobo
    Zhao, Xiaoya
    Wang, Chen
    Lu, Shanshan
    Wang, Yiqin
    He, Yijiao
    Wang, Jianliu
    Shen, Danhua
    ONCOLOGY LETTERS, 2023, 25 (02)
  • [9] Efficacy of fertility-sparing treatment with LNG-IUS is associated with different ProMisE subtypes of endometrial carcinoma or atypical endometrial hyperplasia
    Lv, Xiaofeng
    Guo, Lili
    Wang, Changyu
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (03)
  • [10] Outcome of fertility-sparing treatment with medroxyprogesterone acetate for atypical hyperplasia and endometrial carcinoma in young Japanese women
    Kataoka, H.
    Mori, T.
    Yamamoto, T.
    Sawada, M.
    Kuroboshi, H.
    Tatsumi, H.
    Iwasaku, K.
    Kitawaki, J.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (01) : 11 - 15
12345